$1.310
-0.075 (-5.76%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
MXCT Prediction & Forecast by Similar Chart Analysis
Alphio's MXCT stock price prediction model matches the current MaxCyte Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.33 (+1.62%). The 1-week path is $1.31 (-0.29%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy MaxCyte Inc Stock?
MaxCyte Inc is currently trading at $1.45, which is 69.4% of its 52-week range, indicating it is closer to its high of $1.80 than its low of $0.64. However, the RSI is at 45.41, suggesting that the stock is neither overbought nor oversold. The company has a forward P/E of 0, reflecting uncertainty in future earnings, and a gross margin of 63.86%, which is relatively strong. The main risk is the negative net income reported, with a loss of $8.87 million in Q2 2026, indicating ongoing financial struggles. Therefore, while there are some positive indicators, the overall financial performance and lack of clear upward momentum suggest holding rather than buying right now.
MXCT stock price ended at $1.31 on Thursday, after losing -5.76%
MaxCyte Inc (MXCT) last closed at $1.3099999, losing -5.76%. These facts feed the 1-day and 1-week MXCT price prediction above.
Forecast Drivers
MaxCyte Inc (MXCT) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches MXCT, ranked by similarity.
Seasonality analysis for MXCT
Historically the probability of a positive November return for MXCT is 0.00%. January offers the highest probability of a positive month at 55.74%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for MXCT
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $1.36 | $1.77 | $1.84 | +35.28% |
| Dec 2026 | $1.63 | $2.21 | $2.88 | +68.93% |
In 2026, MaxCyte Inc (MXCT) is projected to range from $1.36 to $2.88.
MaxCyte Inc 2026 monthly forecast
In Nov 2026, MaxCyte Inc is projected to average $1.77, with a low of $1.36 and high of $1.84.
In Dec 2026, MaxCyte Inc is projected to average $2.21, with a low of $1.63 and high of $2.88.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.